➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Mallinckrodt
Express Scripts

Last Updated: September 17, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,653,286


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,653,286
Title: Gonadotropin releasing hormone antagonist
Abstract:The present invention relates to a method to prevent a premature LH surge. The method employs the administration of the gonadotropin releasing hormone antagonist ganirelix in an amount between 0.125-1 mg in combination with exogenous FSH. The method can be used in the treatment of women undergoing controlled ovarian superovulation.
Inventor(s): Mannaerts; Bernadette Maria Julia Louise (Acacialaan, NL), Coelingh Bennink; Herman Jan Tijmen (Melvill van Carnebeelaan, NL), Orlemans; Everardus Otto Maria (Wolvespoor, NL)
Assignee: Akzo Nobel NV (Arnhem, NL)
Application Number:09/446,324
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 6,653,286

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,653,286

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
97201885Jun 20, 1997
PCT Information
PCT FiledJune 16, 1998PCT Application Number:PCT/EP98/03713
PCT Publication Date:December 30, 1998PCT Publication Number: WO98/58657

International Family Members for US Patent 6,653,286

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 302018 ⤷  Try it Free
Australia 8727798 ⤷  Try it Free
Germany 69831241 ⤷  Try it Free
Denmark 0994718 ⤷  Try it Free
European Patent Office 0994718 ⤷  Try it Free
Spain 2247710 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 9858657 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Harvard Business School
Medtronic
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.